RedHill Biopharma Ltd (RDHL)

[Crusader]

GOOD FIND, Midas:

Local news has lately emphasized the recent RDHL press releases...

Now, if the FDA green lights this treatment in JANUARY like I think it will, this company and its stock will be one of the very best trades of early 2021. I like the odds here, even though PFE showed us what FDA emergency approval is like.

Operation “Warp Speed” ends JANUARY 21st, 2021, but Biden administration will have an operation to match Trump’s successful (collapsing efforts) , so Dems can take more credit for “beating COVID” and position early for midterm elections.

So, yes, RDHL stands to benefit under both administrations, as do COVID’s critical care patients.

And as a preview all this, WAIT UNTIL YOU HEAR WHO BIDEN APPOINTS AS FDA :

https://www.msn.com/en-us/news/politics/biden-under-pressure-to-name-new-fda-chief-as-public-faith-in-vaccines-falters/ar-BB1aNGSt?fbclid=IwAR2iz4Yf1Q0BczBYrnf08ANpRetW3c2o7zytr09b33lwxhEZfdpjG2fHAlI

OPERATION BREAK NCK SPEED:


The CDC director does not need Senate confirmation, avoiding a hurdle that could slow that process. That is not the case for the FDA commissioner. As a result, even if Biden moves at breakneck speed to replace outgoing Commissioner Stephen Hahn, it could be weeks after Biden is in the White House before his pick could get to work.

In the meantime, the FDA will face critical decisions about vaccines needed to help put the nation on its path out of the pandemic. Biden will have to rely on a temporary head of the FDA to steer the 17,000-employee agency during one of the most challenging times in its history.

“It’s not ideal timing, for sure,” a former FDA official said. “It’s a huge job.”